Condensates as a Culprit in RAS Activation and Inhibitor Resistance

Hannah C Bergo1,2,3, Logan B Leak1,2,3, Trever G Bivona1,2,3,4

  • 1Department of Medicine, University of California, San Francisco, San Francisco, California.

Cancer Research
|March 7, 2025
PubMed

Insights

ARAF protein forms novel condensates that sustain RAS signaling, driving therapy resistance in cancers. Targeting these ARAF-RAS condensates may overcome resistance to RAS-targeted treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Therapy resistance is a major cause of mortality in oncogene-driven cancers.
  • Understanding resistance mechanisms is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To elucidate a novel resistance mechanism in targeted cancer therapy.
  • To investigate the role of ARAF in RAS-mediated signaling and therapy resistance.

Main Methods:

  • Investigated the function of ARAF in RAS signaling.
  • Utilized techniques to study protein interactions and localization.
  • Examined the role of ARAF in phase-separated condensates.

Main Results:

  • ARAF sequesters active RAS in phase-separated condensates at the plasma membrane.
  • This sequestration sustains MAPK pathway signaling and prevents RAS inactivation by neurofibromin 1.
  • ARAF exhibits a distinct biological role compared to other RAF proteins.

Conclusions:

  • ARAF plays a novel role in sustaining RAS signaling through biomolecular condensates.
  • This mechanism contributes to therapy resistance in RAS-driven cancers.
  • Targeting ARAF-mediated condensates presents a potential strategy to overcome treatment resistance.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
3.9K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
1.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K